Haig Aghajanian
6PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 13, 2026
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.Khuloud Bajbouj, Zebin Xiao, Leslie Todd
|Jan 21, 2026
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin
|Jun 19, 2025
In vivo CAR T cell generation to treat cancer and autoimmune disease.Theresa L Hunter, Yanjie Bao, Yan Zhang
|Mar 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin
|Mar 01, 2022
CAR-based therapies: opportunities for immuno-medicine beyond cancer.Haig Aghajanian, Joel G Rurik, Jonathan A Epstein
|Jan 06, 2022
CAR T cells produced in vivo to treat cardiac injury.Joel G Rurik, István Tombácz, Amir Yadegari
Pageof 1
Frequent Collaborators
4 joint publications
Joel G Rurik
4 joint publications
Jonathan A Epstein
4 joint publications
Tyler E Papp
3 joint publications
Hamideh Parhiz
3 joint publications
Carl H June
2 joint publications
Bruno Cogliati
2 joint publications
Chittampalli N Yashaswini
2 joint publications
Drew Weissman
2 joint publications
Steven M Albelda
2 joint publications
Ellen Puré
